Log In
BCIQ
Print this Print this
 

Morphomer Abeta

  Manage Alerts
Collapse Summary General Information
Company AC Immune S.A.
DescriptionInhibits aggregation of Abeta-oligos
Molecular Target Beta amyloid
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today